Latest news
Bank of America Securities Reaffirms Their Buy Rating on Avalo Therapeutics (AVTX) - The Globe and MailThe Globe and Mail · Sat, 08 Aug 2026 10:59:00 GMTWhy Did AVTX Stock Surge 45% In Pre-Market Today? - StocktwitsStocktwits · Sat, 08 Aug 2026 07:57:20 GMTAVTX Maintains Buy Rating by Guggenheim -- Price Target Lowered to $48 - GuruFocusGuruFocus · Fri, 07 Aug 2026 19:15:45 GMTAVTX Maintained by HC Wainwright & Co. -- Price Target Lowered t - GuruFocusGuruFocus · Fri, 07 Aug 2026 14:33:10 GMTState Street Corporation (NYSE: AVTX custodian) discloses 5.5% Avalo stake - Stock TitanStock Titan · Fri, 07 Aug 2026 12:44:31 GMTAVTX SWOT Analysis: Financial Challenges and Promising Pipeline Revealed in 10-Q Filing - GuruFocusGuruFocus · Fri, 07 Aug 2026 08:03:26 GMTAvalo Therapeutics (NASDAQ:AVTX) Issues Quarterly Earnings Results, Misses Expectations By $0.27 EPS - MarketBeatMarketBeat · Fri, 07 Aug 2026 00:25:36 GMTPrice-Driven Insight from (AVTX) for Rule-Based Strategy - Stock Traders DailyStock Traders Daily · Thu, 06 Aug 2026 23:20:02 GMT